About VPCIR

A World Class biotech team with a common goal.

VPCIR is based on the joined forces of start-up entrepreneur Jan Mousing and the Aarhus University/Chinese University of Hong Kong research teams behind the base patent for VPCIR. Thus joining many years of management experience in the food research industry including instrument development, accreditation, food safety research and food safety control on an EU level with the scientists competencies in pathogens, enzyme based manipulation, nano engineering and large-scale lab automation.

Jan Mousing
Jan Mousing
CEO
VPCIR Commercialization Manager

PhD with more than 20 years of experience in executive management, commercialization and innovation in agri-food and agro-tech. Chief veterinary of leading public and private organisations.

Birgitta R. Knudsen
Birgitta R. Knudsen
CSO
VPCIR Science and Technology Manager

PhD with more than 20 years of experience in university research and commercial R&D in molecular biology specialising in biological functions and DNA modifying enzymes.

Magnus Stougaard
Magnus Stougaard
Implementation Manager
VPCIR Lab Automation Expert

PhD with more than 12 years of experience in university research and commercial R&D specialising in deployment and management of new molecular test systems in large scale laboratories.

Cinzia
Cinzia Tesauro
Head of Research and Early Production
VPCIR Aarhus Research Team Manager

PhD with more than 11 years of experience in R&D in molecular and cellular biology, project management, communication and commercialization.

Megan Yi-Ping HO
VPCIR Nanotechnology Engineer
HK Research Team Manager

PhD with more than 10 years of experience in university research and commercial R&D specialising in nanotechnology and micro-fluidics in medical diagnostics.

Mikael Hansen
Mikael Hansen
CMO
VPCIR Marketing and Relationship Manager

M.Sc in Marketing and Behavioral Psychology with more than 20 years of experience in strategy and marketing, branding, Web, SoMe and CRM solutions, B2B online sales, relationship building and commercial partnerships.

Peter Dybdahl Hede
Peter Dybdahl Hede
Chairman

Peter holds a MSc and PhD in chemical engineering. He is co-founder and chairman of the management board of VPCIR biosciences. Peter is specialized in strategic R&D leadership on an international level within Food, Feed, Agro, Biotech and Enzyme Tech. He is an experienced member in Boards and Advisory boards of start-ups and small/medium-sized companies.

Claus Fertin
Claus Fertin
Partner

Claus holds a PhD in Economics and MSc in Agriculture. He is an expert in international Agribusiness and Biotech. Areas of experience include Change Management, Turn-around and Implementation, Strategy, Mergers & Acquisitions, Manufacturing, Automation, Research & Development, Innovation and IP. Management experience in numerous organizations.

Jens Chr. Jensen
Jens Chr. Jensen
Partner

Jens holds a Cand.Merc.Jur from CBS and is part of the business angel group investing in VPCIR biosciences.
He provides legal assistance to the board and management of VPCIR biosciences aps as well as general management support based on his extensive experiences with business startup companies and their growth strategies – as well as building export capabilities.

Birgitta R. Knudsen
Birgitta R. Knudsen
Partner

Birgitta is a co-inventor of the VPCIR technology. She has extensive experience in R&D in molecular biology – particularly in biological functions and applications of DNA modifying enzymes. She has been an Associate Professor at Aarhus University since 2002 and has been a supervisor and research leader for several years. Her expertise also includes innovation and interaction with industry.

Magnus Stougaard
Magnus Stougaard
Partner

Magnus is a co-inventor of the VPCIR technology. He has a strong R&D and application expertise in new molecular test systems. He was involved in clinical molecular pathology since 2010, responsible for lab development, research and implementation of new methods.
He has vast experience in R&D projects including development and set-up of new methods for detecting mutations, gene rearrangements or changes in expression patterns.

Our partners

Sign up for our newsletter today!

Say Hello